Esmolol for fast heart rate in septic shock
Treatments studied
Part of Infections clinical trials.
This study tests a heart-slowing medicine called esmolol (a beta-blocker) in people with septic shock and a fast heart rate. It uses ultrasound to see if the medicine is safe and helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with septic shock within the past 24 hours
- You are within 72 hours of being admitted to the ICU
- Your heart rate is 100 beats per minute or higher (either regular or irregular rhythm)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called esmolol to see if it helps blood flow in tiny blood vessels under the tongue for people with septic shock. If you have a fast heart rate despite treatment, this trial may help your doctors better manage your condition.
This trial tests whether a heart-rate–controlling medication can better manage a new fast heart rhythm that happens during sepsis shock. It may help reduce heart strain and improve safety compared with standard care.
This Phase 3 trial tests whether landiolol (a short-acting heart-rate–lowering medicine) can improve blood circulation in adults with septic shock whose heart rate is too fast. Doctors will also check that the medication is safe in this critical-care setting.
This trial tests whether landiolol (a short-acting heart-rate–lowering medicine) can reduce deaths compared with standard care in people in septic shock who have a fast heart rate and strong heart pumping. It is meant for a very specific type of critically ill patient while they are on a breathing machine.
This trial checks heart function, specifically blood flow and oxygen delivery, in patients with septic shock. It can help doctors better understand how the heart is working during this severe infection.
This study tests whether starting with extra IV fluids or with blood pressure medication first works better for people with septic shock and very low blood pressure. Patients will be monitored with ultrasound to see how their heart and blood vessels respond.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.